ECP therapy

DEVICE2 trials

Sponsors

Vorpal Technologies K.K., Insel Gruppe AG, University Hospital Bern

Conditions

Chronic GVHD after hematopoietic stem cell transplantationCoronary Artery Disease

Unknown Phase

External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease

CompletedNCT00414297

Insel Gruppe AG, University Hospital BernCoronary Artery Disease

Start: 2006-08-31End: 2009-06-30Updated: 2010-10-26

Clinical Study of TC-V in Patients with Chronic GVHD

Active, not recruitingJPRN-UMIN000014634

Vorpal Technologies K.K.Chronic GVHD after hematopoietic stem cell transplantation

Start: 2014-07-28Target: 10Updated: 2026-06-29

Related Papers

Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.

2012-10-0830 citations